Maryland legislation · 2026 Regular Session
Maryland HB1114: HIV Prevention Drugs - Prescribing, Dispensing, and Insurance Coverage
Status: In committee, February 11, 2026
Authorizing pharmacists to prescribe and dispense preexposure prophylaxis for HIV prevention to patients under certain circumstances; prohibiting managed care organizations, insurers, nonprofit health service plans, and health maintenance organizations from requiring prior authorization for preexposure prophylaxis for HIV prevention or step therapy or cost sharing for preexposure prophylaxis for HIV prevention or postexposure prophylaxis for HIV prevention; etc.
What the bill says
A bill ENTITLED AN ACT concerning HIV Prevention Drugs - Prescribing, Dispensing, and Insurance Coverage FOR the purpose of authorizing pharmacists to prescribe and dispense preexposure prophylaxis for HIV prevention to patients under certain circumstances; requiring the Maryland Medical Assistance Program to provide drugs that are approved by the U.S. Food and Drug Administration for HIV prevention…
From the introduced text, February 11, 2026:
A BILL ENTITLED AN ACT concerning HIV Prevention Drugs - Prescribing, Dispensing, and Insurance Coverage FOR the purpose of authorizing pharmacists to prescribe and dispense preexposure prophylaxis for HIV prevention to patients under certain circumstances; requiring the Maryland Medical Assistance Program to provide drugs that are approved by the U.S. Food and Drug Administration for HIV prevention; prohibiting managed care organizations, insurers, nonprofit health service plans, and health maintenance organizations from requiring prior authorization for preexposure prophylaxis for HIV prevention or step therapy or cost-sharing for preexposure prophylaxis for HIV prevention or postexposure prophylaxis for HIV prevention; requiring the State Board of Pharmacy to develop a certain notification plan and convene a certain workgroup; and generally relating to HIV prevention drugs. BY adding to Article - Health - General Section 15-102.3(p) and 15-103(a)(2)(xxix) Annotated Code of Maryland (2023 Replacement Volume and 2025 Supplement) BY repealing and reenacting, without amendments, Article - Health - General Section 15-103(a)(1) Annotated Code of Maryland (2023 Replacement Volume and 2025 Supplement) BY repealing and reenacting, with amendments, Article - Health - General Section 15-103(a)(2)(xxvii) and (xxviii) and (b)(32) Annotated Code of Maryland (2023 Replacement Volume and 2025 Supplement) EXPLANATION: CAPITALS INDICATE MATTER ADDED TO EXISTING LAW. [Brackets] indicate matter deleted from exist in g l aw . *hb1114* HOUSE BILL 1114 BY repealing and reenacting, …
Sponsors
- Ashanti Martinez (D, 22) · primary sponsor
- Gabriel Acevero (D, 39)
- Luke Clippinger (D, 46)
- Kris Fair (D, 3)
- Anne Kaiser (D, HD-014)
- Aaron Kaufman (D, HD-018)
- Joe Vogel (D, 17)
- Teresa Woorman (D, 16)
Latest actions
- : Hearing 3/04 at 1:00 p.m.
- : First Reading Health
Common questions
- What is HB1114?
- HB1114 is a bill in the Maryland Legislature (2026 Regular Session): HIV Prevention Drugs - Prescribing, Dispensing, and Insurance Coverage.
- What does HB1114 do?
- In its own words: A bill ENTITLED AN ACT concerning HIV Prevention Drugs - Prescribing, Dispensing, and Insurance Coverage FOR the purpose of authorizing pharmacists to prescribe and dispense preexposure prophylaxis for HIV prevention to patients under certain circumstances; requiring the Maryland Medical Assistance Program to provide drugs that are approved by the U.S. Food and Drug Administration for HIV prevention…
- What is the status of HB1114?
- In committee as of February 11, 2026. Latest action: Hearing 3/04 at 1:00 p.m. (February 11, 2026).
- Who sponsored HB1114?
- Ashanti Martinez (D, 22), with 7 co-sponsors.
- Where is the official record for HB1114?
- On the Maryland Legislature website: https://mgaleg.maryland.gov/mgawebsite/Legislation/Details/hb1114?ys=2026RS
Source: official Maryland record. Tracked by Delilah, AI for legislation across all 50 states and Congress.